Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally

Focused on precision oncology and rare genetic diseases, this biotech reported a significant insider sale amid strong one-year stock gains.

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight ...
IEEE

A Bayesian Implementation of Quality-by-Design for the Development of Cationic Nano-Lipid for siRNA Transfection

Abstract: Unlike Quality by Testing approach, where products were tested only after drug manufacturing, Quality by Design (QbD) is a proactive control quality paradigm, which handles risks from the ...

Study finds combined gene mutations better mimic rare gut disorder in mice

During development of the digestive system, a complex network of nerves forms around it, creating a "second brain"—the enteric nervous system (ENS)—which controls the movement of food and waste ...
IEEE

Blood-brain barrier disruption for the delivery of non-infectious viral vectors and proteins, preliminary study

Abstract: Angelman syndrome (AS) is a rare neuro-genetic disorder caused by loss of expression of the maternal copy of UBE3A in the brain inducing severe mental and physical impairments. Due to ...